-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
Beijing, China and Cambridge, Massachusetts, December 20, 2021/PRNewswire/ - BeiGene (Nasdaq: BGNE: Hong Kong Stock Exchange: 06160; Shanghai Stock Exchange: 688235) is a global company A biotechnology company that focuses on developing and commercializing innovative drugs worldwide, improving treatment outcomes and increasing the availability of drugs for patients around the world
Mr.
Dr.
Enabling innovation and growth, exploring the vast unknown
The Bio-Island Innovation Center is located in the core area of the biomedical industry in the Guangdong-Hong Kong-Macao Greater Bay Area
The innovation center has an advanced and comprehensive technology platform that can give scientists and entrepreneurs more control, so that they can focus more on their favorite fields and help them grow quickly
Dr.
Dr.
About BeiGene
BeiGene is a science-based global biotechnology company that focuses on the development of innovative and affordable drugs to improve treatment outcomes and access to drugs for patients around the world
Forward-looking statement
This press release contains forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including the plans and ambitions of BeiGene Bio-Island Innovation Center and " About The plans, commitments, ambitions and goals of BeiGene mentioned under "BeiGene"